The FDA approved SeaStar Medical’s (NASDAQ:ICU) investigational device exemption application to conduct a pivotal study evaluating the effectiveness of its Selective Cytopheretic Device (SCD) in reducing...
SeaStar Medical (NASDAQ:ICU) expects an FDA decision in the first quarter on a humanitarian device exemption application to use its Selective Cytopheretic Device (SCD) to treat the life-threatening effects of...
SeaStar Medical completed a business combination with LMF Acquisition Opportunities (NASDAQ:LMAO), a special purpose acquisition company sponsored by LM Funding America (NASDAQ:LMFA). The combined company was renamed...
Shareholders of LMF Acquisition Opportunities (NASDAQ:LMAO) voted at a special meeting to approve a business combination with SeaStar Medical, a medical technology company developing proprietary solutions to reduce the...